Literature DB >> 21078068

Subjects with sonographical hepatic steatosis should be excluded from studies to establish upper reference levels of serum transaminases.

Henry Völzke1, Dietrich Alte, Till Ittermann, Carsten O Schmidt, Rainer Rettig, Julia Mayerle, Albert B Lowenfels, Markus M Lerch, Matthias Nauck.   

Abstract

BACKGROUND AND AIMS: Correct upper reference limits (URL) of serum liver enzyme activities are used to select individuals in whom further diagnostic procedures for suspected liver disorders are warranted and to compare the prevalence and incidence of increased serum liver enzyme levels within and among populations. We sought to establish URL in a general adult population by not only generating a disease-free population but also further excluding subjects with ultrasonographical diagnosis of hepatic steatosis.
METHODS: We used data from 4,242 subjects (2,154 women) aged 20-79 years recruited for the population-based Study of Health in Pomerania. A reference population was selected comprising 1,953 subjects (1,129 women). Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyltransferase (GGT) were measured photometrically.
RESULTS: The exclusion of 630 subjects with hepatic steatosis and 20 subjects with equivocal data on liver ultrasound from the reference population predominantly affected the URL for serum ALT and GGT levels in younger age groups. URL for serum ALT, AST and GGT levels were 1.00 μmol/L/s (60 U/L), 0.55 μmol/L/s (33 U/L) and 1.11 μmol/L/s (67 U/L), respectively, in men as well as 0.57 μmol/L/s (34 U/L), μmol/L/s (25 U/L) and μmol/L/s (39 U/L), respectively, in women.
CONCLUSIONS: URL for serum liver enzyme activities are higher than recommended previously. Creating a reference population for establishing URL for serum liver enzyme activities should include liver ultrasound in order to exclude subjects with subclinical hepatic steatosis.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078068     DOI: 10.1111/j.1478-3231.2010.02371.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

1.  Upper limits of normal for alanine aminotransferase activity in the United States population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  Influence of the definition of "metabolically healthy obesity" on the progression of coronary artery calcification.

Authors:  Ji Won Yoon; Chan-Hyeon Jung; Min-Kyung Kim; Hyo Eun Park; Kyong Soo Park; Hak Chul Jang; Min Kyong Moon; Su-Yeon Choi; Bo Kyung Koo
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 3.  Alanine aminotransferase-old biomarker and new concept: a review.

Authors:  Zhengtao Liu; Shuping Que; Jing Xu; Tao Peng
Journal:  Int J Med Sci       Date:  2014-06-26       Impact factor: 3.738

4.  Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.

Authors:  Amedeo Lonardo; Dante Romagnoli
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

5.  Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update.

Authors:  Luca Valenti; Serena Pelusi; Cristiana Bianco; Ferruccio Ceriotti; Alessandra Berzuini; Laura Iogna Prat; Roberta Trotti; Francesco Malvestiti; Roberta D'Ambrosio; Pietro Lampertico; Agostino Colli; Massimo Colombo; Emmanuel A Tsochatzis; Mirella Fraquelli; Daniele Prati
Journal:  Hepatol Commun       Date:  2021-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.